Conversion to Aflibercept After Prior Anti-VEGF Therapy for Persistent Diabetic Macular Edema
Abstract
The study by Rahimy and associates 1 Rahimy E. Shahlaee A. Ali Khan M. et al. Conversion to aflibercept after prior anti-VEGF therapy for persistent diabetic macular edema. Am J Ophthalmol. 2016; 164: 118-127 Abstract Full Text Full Text PDF PubMed Scopus (67) Google Scholar assessed the short-term visual and anatomic outcomes of patients with persistent diabetic macular edema (DME) who were converted from bevacizumab (Avastin; Genentech, Inc,...
Paper Details
Title
Conversion to Aflibercept After Prior Anti-VEGF Therapy for Persistent Diabetic Macular Edema
Published Date
Aug 1, 2016
Volume
168
Pages
290 - 291
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History